LONDON—Hematopoietic stem cells are not displaced and depleted by malignant cells in patients with acute myeloid leukaemia but merely put to sleep, according to research from London published in PNAS Early Edition. Professor John Gribben from Barts Cancer Institute in London discusses their finding and explains how this gives new opportunities for treating AML.
You may also like...
ARCON Improved Quality of Life in Advanced Laryngeal Cancer: Phase-III ARCON Trial 11 May, 2015 Virus Plus Cytokine Fight Primary and Metastatic Cancer 15 Aug, 2007 Schistosomiasis: sanitation plus free drug supplies bring hope of elimination 27 Nov, 2012 Audio Journal of Oncology Volume 16 Number 11 3 Jun, 2008
- Previous story Chimeric antigen receptor T-cell therapy rescues kids with relapsing acute lymphoblastic leukaemia
- Next story Normal stem cells are not depleted in acute myeloid leukaemia and could be targeted therapeutically
- Ultrahypofractionated Radiation Just As Effective for Prostate CancerMay 16, 2018
- First evidence that genome editing made patients with AIDS more resistant to HIVMarch 8, 2014
- Anticoagulation with warfarin can be beneficial in patients with atrial fibrillation and chronic kidney disease.March 7, 2014
- Prostate cancer: Adult exposure to bisphenol-A linked to prostate cancer riskMarch 6, 2014
- MMR vaccine’s non-specific effects: adherence to recommended vaccination schedules protects children against non-vaccination-specific infections tooFebruary 28, 2014